Background. Male adolescents with constitutional delay of growth and p
uberty may have significant psychosocial difficulties related to their
sexual immaturity and short stature. The purpose of this study was to
test the hypothesis that 1 year of oxandrolone therapy would increase
growth velocity and thereby improve psychosocial functioning in boys
with constitutional delay of growth and pubertal development. Methods.
Forty boys (ages 11 to 14.7 years) with delayed pubertal development
and short stature were recruited from the pediatric endocrine clinics
of 14 medical centers. The boys were randomized using a block design s
tratified for age to receive either oxandrolone (0.1 mg/kg daily for 1
year) or an identical-appearing placebo tablet, using a double-masked
design. Results. Growth velocity in the oxandrolone-treated boys was
significantly greater than in the control boys (9.5 vs 6.8 cm/y). Like
wise, the mean height SD score increased 0.41 in the oxandrolone group
, whereas it decreased 0.03 in the control group. Those in the oxandro
lone group gained 2.4 kg more than those in the placebo group. Mean pr
edicted adult heights did not change in either group. The mean rates o
f pubertal progression were equivalent in both groups. Self-image (Pie
rs-Harris Self Concept Scale) and social competence (Child Behavior Pr
ofile) were normal at baseline in both groups and did not change signi
ficantly over the course of the study in either group. No complication
s of oxandrolone therapy were identified. Conclusions. This randomized
, placebo-controlled trial demonstrates that low-dose oxandrolone can
increase both height and weight velocity in boys with delayed puberty
safely. Under the conditions of this study, however, the increased gro
wth velocity in the oxandrolone-treated boys was not associated with a
greater improvement in psychosocial status compared with the control
boys.